GSE168583
Characterization of Early Gilteritinib Resistant Cell Lines
Expression analysis performed on Early Gilteritinib Resistant cell lines vs Acute (48hr) treatment and MOLM14 Parental Overall design: Comparison between Early Resistant and Acute as well as Early Resistant vs MOLM14 Parental